The assembly of phage 4)29 occurs by a single pathway, and the DNA protein (DNA-gp3) of "packaging intermediates" can be obtained after DNase I interruption of in vitro complementation. A broad spectrum of DNA molecules of variable length was isolated from DNase I-treated proheads. Restriction endonuclease EcoRI digestion and electrophoretic analysis of these DNA molecules suggested that DNA-gp3 packaging was oriented with respect to the physical map and was a complex process. Proteinase K-treated exogenous DNA was not packaged. When exogenous DNA-gp3 was predigested with the restriction endonucleases BstEII, EcoRI, HpaI, and HpaII, the left-end fragments, ranging in size from 8 to 0.9 megadaltons, were selectively and efficiently packaged. During in vivo and in vitro assembly, DNA-gp3 is packaged into proheads, the "core-scaffolding" protein gp7 exits from the particles, and the DNA-filled heads assume the angular morphology of phage 4)29. The packaging of a 4.1-megadalton DNA-gp3 left-end fragment (one third of the genome) resulted in the exit of gp7 and the transition to angularity. MATERIALS AND METHODS Chemicals and isotopes. Spermidine (A grade) and DNase I (bovine pancreatic) were obtained from Calbiochem-Behring Corp., San Diego, Calif. ATP (equine muscle) and egg white lysozyme (3 x recrystallized) were purchased from Sigma Chemical Co., St. Louis, Mo. ATP was dissolved in TMS buffer (0.05 M Tris-hydrochloride [pH 7.8], 0.01 M MgCl2, 0.1 M NaCI) and neutralized with 1.5 N ammonium hydroxide to give a stock solution of 20 mM (pH 7.8). Proteinase K (E. Merck, Darmstadt, West Germany) was dissolved in water. High-gelling-temperature agarose was from FMC Corp., Rockland, Maine, and 2mercaptoethanol was obtained from Eastman Chemical Co., Rochester, N.Y. The restriction endonucleases EcoRI, BstEIl, Haelll, and Hpall were purchased from Bethesda Research Labs, Rockville, Md., and Hpal was from Boehringer-Mannheim Biochemical, Indianapolis, Ind. [3H]thymidine (no. NET 0272; 50 Ci/mmol) and the "C-labeled amino acid mixture (no. NEC 445E; about 200 mCi/ mmol) were from New England Nuclear Corp., Boston, Mass. Phage and bacteria. Phage 4)29 and previously described mutants were used (39, 47). Recombinants were constructed with mutant susl4(1241), a mutation that results in the delayed-lysis phenotype (42). The properties of the permissive host B. subtilis sup44 (40) and the nonpermissive host B. siubtilis spoA12 (48) have been described previously.